Chapter 122
Chapter 122
Back in New York, the familiarity of their foundation’s headquarters was both comforting and sobering for Emma and Thomas. The whirlwind of their Italian honeymoon and conference had left them energized with new ideas, but the weight of Marco Verdi’s proposal still lingered heavily in their minds. It was impossible to ignore the potential impact of such substantial funding—or the conditions attached to it.
The two sat in Emma’s office, surrounded by stacks of research reports and files. The morning sunlight filtered through the large windows, highlighting the seriousness etched on both their faces.
Thomas leaned back in his chair, crossing his arms. “Unlimited resources, access to cutting-edge technology, and a global platform. Verdi knows how to make an offer sound irresistible.”
Emma sighed, tapping her pen against her notebook. “But at what cost? Exclusivity on research findings means limited access for the people who need it most. That goes against everything we’ve built this foundation to stand for.”
Thomas leaned forward, his tone contemplative. “It’s not just the exclusivity. It’s the shared decision-making. If Verdi Ventures holds that much power, they could easily prioritize profit over accessibility.”
Emma looked out the window, her mind racing. She thought of the families who wrote to her, thanking her for the work the foundation had done. She thought of the patients who depended on their initiatives—not just for hope, but for survival. Could she risk compromising that trust for the sake of acceleration?
“But think about what we could accomplish,” Thomas added, his voice soft but insistent. “With that kind of funding, we could scale our efforts globally in ways we’ve only dreamed of. We could reach millions, maybe even billions, faster than we ever imagined.”
Emma turned to face him, her gaze conflicted. “And if we give up control? If they take that power and use it to put profits ahead of people? We’d have all the resources in the world, but no say in how they’re used.”
Thomas reached out, placing a hand on hers. “We need clarity, Emma. Let’s get an outside perspective—someone who can analyze this offer objectively and help us see the risks and rewards clearly.”
Emma nodded, her resolve strengthening. “You’re right. We need someone who understands the nuances of this, someone who can help us figure out if this is even worth considering.”
The next morning, Emma reached out to Dr. Annika Groves, an ethical compliance consultant known for her work in navigating complex partnerships between nonprofit organizations and private investors. By the afternoon, they were seated across from Annika in the foundation’s boardroom, the investor proposal spread out on the table.
Annika was a sharp, no-nonsense woman in her early fifties, with silver-streaked hair pulled into a neat bun and glasses perched on the edge of her nose. She studied the documents intently, occasionally scribbling notes in her leather-bound notebook.
“This is an impressive offer,” Annika said finally, her tone neutral. “But it’s also a carefully constructed trap.”
Emma and Thomas exchanged a glance. “Go on,” Emma prompted.
Annika gestured to the exclusivity clause. “This language essentially locks you into a partnership where Verdi Ventures dictates the terms of access to the treatments you develop. If they decide to charge exorbitant fees or restrict access to high-income regions, there’s little you can do to stop them.”
She flipped to another section. “And the shared decision-making clause is vague—intentionally so. It gives Verdi Ventures room to exert influence over nearly every aspect of the initiative, from research priorities to deployment strategies.”
Thomas frowned. “Is there any way to structure this so we maintain control while still benefiting from their funding?”
Annika hesitated, tapping her pen against the table. “It’s possible, but unlikely. Companies like Verdi Ventures don’t invest out of altruism. They’ll expect a significant return on investment, and that return often comes at the expense of the people you’re trying to serve.”
Emma leaned forward, her voice filled with frustration. “So what’s the alternative? We reject the offer and continue at our current pace, knowing we could be leaving life-saving advancements on the table?”
Annika regarded her thoughtfully. “There’s always a balance, Emma. The question you need to answer is this: What are you willing to compromise, and what’s non-negotiable?”
After Annika left, Emma and Thomas retreated to her office, the weight of the decision pressing down on them. Emma sat at her desk, staring at the proposal but seeing the faces of the people their foundation had helped over the years.
“I don’t want to slow down,” she said quietly. “But I can’t stomach the idea of families being priced out of treatments we’ve fought so hard to develop.”
Thomas nodded, pacing the room. “I feel the same way. But what if there’s a middle ground? What if we negotiate terms that limit their influence?”
Emma rubbed her temples, exhaustion creeping in. “It’s worth exploring, but I don’t trust Verdi. He’s too polished, too calculated. Even if we find a middle ground, what’s to stop him from finding a loophole later?”
Thomas stopped pacing and stood in front of her, his hands resting on her desk. “Then we make our priorities clear. Transparency. Accessibility. Non-negotiable. If they can’t meet us there, we walk.”
Emma looked up at him, her expression softening. “You always know how to make the impossible feel manageable.”
Thomas smiled, his voice warm. “Because I know you’ll find a way. You always do.”
Over the next few days, Emma and Thomas worked closely with Annika to draft a counterproposal. They outlined their non-negotiables in clear, uncompromising terms: open access to research findings, affordable treatment pricing, and full control over deployment strategies. The revised proposal was sent to Verdi Ventures with a request for a meeting to discuss the terms.
The wait for a response was nerve-wracking. Emma threw herself into her work, focusing on the foundation’s ongoing initiatives to distract herself from the uncertainty. Thomas, ever the pragmatist, reviewed contingency plans in case Verdi rejected their terms.
Finally, a reply came. Verdi Ventures agreed to a meeting, scheduled for the following week. Emma felt a mix of relief and apprehension. This was their chance to fight for what they believed in—but it was also a test of how far Verdi Ventures was willing to go to secure the partnership.
On the day of the meeting, Emma and Thomas arrived at Verdi Ventures’ sleek headquarters, a glass-and-steel skyscraper that loomed over the city. They were escorted to a spacious conference room where Marco Verdi waited, his signature charm on full display.
“Emma, Thomas, welcome,” Marco said, extending a hand to each of them. “I’m glad we’re having this conversation. I’ve been looking forward to hearing your thoughts.”
Emma placed their revised proposal on the table, her voice steady but firm. “We’ve outlined the terms under which we’d be willing to move forward. These are non-negotiable.”
Marco opened the document, his expression unreadable as he scanned the pages. After a moment, he closed it and leaned back in his chair, steepling his fingers. “You drive a hard bargain, Ms. Stone. I respect that. But I’ll need some time to review this with my team.”
“Take all the time you need,” Emma replied, meeting his gaze. “We won’t compromise on the principles that define our foundation.”
Marco’s smile was polite but thin, his eyes glinting with something Emma couldn’t quite place. “Understood. I’ll be in touch.”
As Emma and Thomas left the building, Emma felt a flicker of uncertainty. Had they done enough to protect their mission, or had they set themselves up for a battle they couldn’t win?
“I trust you, Emma,” Thomas said as they stepped onto the bustling city sidewalk. “Whatever happens, we’ll stand by what’s right.”
Emma nodded, her resolve hardening. They had drawn their line in the sand. Now all they could do was wait—and hope that Verdi Ventures was willing to meet them there.
________________
novelraw